Panagora Asset Management Inc. Acquires 637,907 Shares of Ventas, Inc. $VTR

Panagora Asset Management Inc. raised its holdings in Ventas, Inc. (NYSE:VTR) by 86.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,371,835 shares of the real estate investment trust’s stock after buying an additional 637,907 shares during the quarter. Panagora Asset Management Inc.’s holdings in Ventas were worth $106,153,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Bridgewater Advisors Inc. increased its holdings in Ventas by 2.0% in the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock valued at $525,000 after buying an additional 133 shares during the period. True Wealth Design LLC increased its holdings in Ventas by 32.0% in the 4th quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after buying an additional 138 shares during the period. Cigna Investments Inc. New increased its holdings in Ventas by 3.3% in the 4th quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock valued at $341,000 after buying an additional 142 shares during the period. Parallel Advisors LLC grew its holdings in shares of Ventas by 4.6% in the 3rd quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock worth $278,000 after purchasing an additional 175 shares during the last quarter. Finally, HighTower Advisors LLC grew its holdings in shares of Ventas by 0.4% in the 3rd quarter. HighTower Advisors LLC now owns 42,092 shares of the real estate investment trust’s stock worth $2,946,000 after purchasing an additional 182 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Insider Transactions at Ventas

In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the sale, the director owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This represents a 3.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler acquired 2,500 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The shares were bought at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the acquisition, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.53% of the stock is owned by corporate insiders.

Ventas Stock Down 0.0%

VTR opened at $84.58 on Monday. The firm’s 50-day simple moving average is $85.15 and its 200-day simple moving average is $82.51. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. Ventas, Inc. has a twelve month low of $61.76 and a twelve month high of $91.06. The firm has a market cap of $41.12 billion, a price-to-earnings ratio of 153.79, a PEG ratio of 1.82 and a beta of 0.71.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the company earned $0.84 EPS. The firm’s revenue was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Equities research analysts anticipate that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.52 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Ventas’s dividend payout ratio is currently 378.18%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Wells Fargo & Company upped their target price on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Scotiabank upped their target price on shares of Ventas from $93.00 to $95.00 and gave the stock a “sector perform” rating in a report on Thursday, May 21st. KeyCorp upped their target price on shares of Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Mizuho set a $98.00 target price on shares of Ventas in a report on Friday, May 22nd. Finally, Royal Bank Of Canada upped their target price on shares of Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a report on Monday, May 4th. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $95.19.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.